Fairhaven Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,392
| Closed | -$243K | – | 127 |
|
|
2024
Q3 | $243K | Sell |
8,392
-999
| -11% | -$28.9K | 0.07% | 101 |
|
|
2024
Q2 | $263K | Buy |
9,391
+1,091
| +13% | +$30.5K | 0.09% | 98 |
|
|
2024
Q1 | $230K | Sell |
8,300
-2,188
| -21% | -$60.7K | 0.08% | 106 |
|
|
2023
Q4 | $302K | Buy |
10,488
+1,559
| +17% | +$44.9K | 0.11% | 81 |
|
|
2023
Q3 | $296K | Sell |
8,929
-9,371
| -51% | -$311K | 0.12% | 79 |
|
|
2023
Q2 | $671K | Buy |
+18,300
| New | +$671K | 0.26% | 48 |
|
|
2022
Q4 | $994K | Sell |
19,400
-524
| -3% | -$26.9K | 0.42% | 41 |
|
|
2022
Q3 | $872K | Buy |
19,924
+333
| +2% | +$14.6K | 0.39% | 42 |
|
|
2022
Q2 | $1.03M | Sell |
19,591
-1,017
| -5% | -$53.3K | 0.48% | 38 |
|
|
2022
Q1 | $1.07M | Hold |
20,608
| – | – | 0.43% | 39 |
|
|
2021
Q4 | $1.22M | Sell |
20,608
-111
| -0.5% | -$6.56K | 0.47% | 40 |
|
|
2021
Q3 | $891K | Sell |
20,719
-427
| -2% | -$18.4K | 0.37% | 43 |
|
|
2021
Q2 | $828K | Sell |
21,146
-2,663
| -11% | -$104K | 0.33% | 44 |
|
|
2021
Q1 | $863K | Sell |
23,809
-21,774
| -48% | -$789K | 0.36% | 43 |
|
|
2020
Q4 | $1.68M | Buy |
45,583
+14,177
| +45% | +$522K | 0.74% | 33 |
|
|
2020
Q3 | $1.09M | Buy |
+31,406
| New | +$1.09M | 0.65% | 34 |
|